Webb10 aug. 2024 · Shanghai PerHum Therapeutics Co., Ltd. Collaborator Shanghai Zhongshan Hospital Provider of Information About this Clinical Study Sponsor Conditions in This Trial Solid Tumor Gastric Cancer Breast Cancer Ovarian Cancer Sarcoma Additional Key Areas Provided by Investigators HER2 CAR-T Solid tumors Interventions in This Trial CCT303-406
CCT301-59 CAR T Therapy in Adult Subjects With Recurrent or …
Webb23 maj 2024 · - German biotechnology company Exuma biotechnology and affiliate Shanghai PerHum Therapeutics have presented interim results of two first-in-human … WebbPerhum therapeutics has developed a modified chimeric antigen receptor ... Shanghai Pu'er Biotechnology Overview. Founded Year 2016. Location Shanghai, China. Company Stage Funding Raised. Similar Cos. Ginkgo Bioworks, Human Longevity, Amyris, Bionano Genomics, Relay Therapeutics & 3271 others. how are beowulf and his birth described
Shanghai PerHum Therapeutics Co. Ltd. - Company Profiles - BCIQ
Webb22 mars 2024 · For HER2 Positive Breast Cancer Emerging drugs, the HER2 Positive Breast Cancer pipeline analysis report provides a 360° view of the therapeutics landscape by development point, product type ... Webb13 sep. 2024 · Shanghai Ming Ju Biotechnology Co., Ltd. ClinicalTrials.gov Identifier: NCT04089215 Other Study ID Numbers: JWCAR029-002 : First Posted: September 13, 2024 Key Record Dates: Last Update Posted: January 22, 2024 Last Verified: January 2024 Individual Participant Data (IPD) Sharing Statement: Plan to Share IPD: No WebbMAINZ, Germany--(BUSINESS WIRE)--EXUMA Biotechnology and affiliate Shanghai PerHum Therapeutics announced today interim results of two first-in-human solid tumor CAR-T … how are benzodiazepines metabolized